Surgery, Gastroenterology and Oncology
Vol. 25, No. 1, Feb 2020
Rationale for Neoadjuvant Chemotherapy of Resectable Colorectal Cancer Liver Metastases: When is it Useful?
Hiroto Kikuchi, Shuichi Aoki, Dan G. Duda, Kohei Shigeta
REVIEW, Feb 2020
Article DOI: 10.21614/sgo-25-1-4
Colorectal cancer is the third most common cancer and the third leading cause of cancer death in the United States (1). Moreover, approximately 20% of patients are diagnosed with synchronous colorectal liver metastases (CRLMs)(2). For patients with CRLM, the 5-year survival rate with after chemotherapy alone is approximately 11 percent (3). However, the 5-year and 10-year survival rates after surgical resection are reported as 38% and 26%, respectively (4). Therefore, surgery is considered a potentially curative intervention in CRLM.
Unfortunately, not all CRLM patients are candidate for liver resection due to several factors.These include medical comorbidities and anatomical factors such as the number of metastases, tumor size and margin.
In some cases, chemotherapy for unresectable tumors could convert the tumors to resectable. In other cases, neoadjuvant chemotherapy can help patients with synchronous metastatic disease undergo performed staged resection.
Although neoadjuvant chemotherapy could be useful, its implementation is not yet standard and its use in resectable CRLM remains controversial. This review article focuses on the potential utility of neoadjuvant therapy for CRLMs.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 1880


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Sept 2023

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/